SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-032975
Filing Date
2024-02-13
Accepted
2024-02-13 08:44:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d774146d424b5.htm 424B5 465408
2 EX-FILING FEES d774146dexfilingfees.htm EX-FILING FEES 10528
3 GRAPHIC g774146g00a01.jpg GRAPHIC 31733
4 GRAPHIC g774146g05j89.jpg GRAPHIC 34208
  Complete submission text file 0001193125-24-032975.txt   556781
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258274 | Film No.: 24622730
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)